Board Meeting22 Oct 2026, 06:10 pm
Senores Pharmaceuticals Ltd Board Meeting on Oct 29, 2026
AI Summary
Senores Pharmaceuticals Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda items include the consideration and approval of the Un-audited Consolidated and Standalone Financial Results for the quarter and half-year ended September 30, 2026. Additionally, the board will address other business matters. The company also reminded stakeholders that the trading window for securities, which was closed from October 1, 2026, will remain shut until 48 hours after the financial results are officially submitted to the stock exchanges, in accordance with the company's insider trading code.
Key Highlights
- Board meeting scheduled for October 29, 2026.
- To approve un-audited financial results for Q2 FY27.
- Trading window closure extended until results are announced.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from SENORES